The primary systemic vasculitis associated optic neuritis: a retrospective analysis in a single center over 10 years
International Ophthalmology · 2024
DOI: 10.1007/s10792-024-03307-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, 2024. Verfasst von Simeng Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China. Hauptthemen laut MEDLINE: Optic Neuritis, Magnetic Resonance Imaging. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital's Funds for Health Improvement and Research (CFH), Capital’s Funds for Health Improvement and Research.
Abstract (Originalsprache)
Objectives
To investigate the clinical and image characteristics of primary systemic vasculitis-associated optic neuritis patients.
Methods
This is a retrospective study. The patients clinically diagnosed with primary system vasculitis-induced optic neuritis were recruited from March 2013 to December 2023. All cases received orbital magnetic resonance imaging scans were analyzed. The ocular findings, systemic manifestations, laboratory data and prognosis were reviewed retrospectively. In addition, the related literature was reviewed.
Results
Fourteen patients (21 eyes), including 10 men and 4 women, were enrolled in this study. The ages ranged from 30 to 86 years in this cohort. Orbits MRI detects the enlargement and/or enhancement of the optic nerve. Cases 1–5 reported a confirmed diagnosis of Takayasu’s arteritis, and cases 6–8 had giant cell arteritis. Cases 9–13 were antineutrophil cytoplasmic antibody-associated vasculitis. Case 14 was Cogan’s syndrome. Mult organs and tissues, such as the kidneys, heart, paranasal sinuses, meninges, and respiratory system, were involved. In all of the 14 involved patients, the disease onset was either during the fall or winter season. There were no or only slight improvements in visual activity after conventional therapies.
Conclusions
The autoantibodies’ attack on the optic nerve, ischemic damage, or destruction of the blood–brain barrier may be the potential pathogenesis of vasculitis-associated optic neuritis. Even with prompt and aggressive clinical interventions, the prognosis remains unsatisfactory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
- Department of Rheumatology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
- Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
- Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
- Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China. faraway_sweet@163.com.
- Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China. hyl_0730@126.com.
Förderung
- Capital's Funds for Health Improvement and Research (CFH)
- Capital’s Funds for Health Improvement and Research
Zitieren
APA
Tang, S., Zhou, H., Li, R., Wang, Y., Li, H., & Hou, Y. (2024). The primary systemic vasculitis associated optic neuritis: a retrospective analysis in a single center over 10 years. International Ophthalmology. https://doi.org/10.1007/s10792-024-03307-2
Vancouver
Tang S, Zhou H, Li R, Wang Y, Li H, Hou Y. The primary systemic vasculitis associated optic neuritis: a retrospective analysis in a single center over 10 years. International Ophthalmology. 2024. doi:10.1007/s10792-024-03307-2
BibTeX
@article{Tang2024,
author = {Tang, Simeng and Zhou, Hang and Li, Rui and Wang, Yu and Li, Hongyang and Hou, Yanli},
title = {The primary systemic vasculitis associated optic neuritis: a retrospective analysis in a single center over 10 years},
journal = {International Ophthalmology},
year = {2024},
doi = {10.1007/s10792-024-03307-2}
}
EUVIMED